Consilio Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
928
+19
+2% +$19.4K 0.27% 41
2026
Q1
$836K Buy
909
+23
+3% +$23.3K 0.24% 39
2025
Q4
$952K Buy
886
+10
+1% +$9.56K 0.28% 36
2025
Q3
$668K Sell
876
-6
-0.7% -$4.46K 0.22% 37
2025
Q2
$684K Sell
882
-11
-1% -$8.55K 0.24% 37
2025
Q1
$738K Buy
893
+54
+6% +$44.9K 0.31% 32
2024
Q4
$648K Buy
839
+3
+0.4% +$2.48K 0.26% 34
2024
Q3
$741K Buy
836
+92
+12% +$82.7K 0.31% 33
2024
Q2
$674K Buy
744
+19
+3% +$15.2K 0.3% 33
2024
Q1
$564K Buy
725
+61
+9% +$43.4K 0.26% 35
2023
Q4
$387K Buy
664
+144
+28% +$84.1K 0.2% 37
2023
Q3
$273K Buy
520
+37
+8% +$19.1K 0.16% 41
2023
Q2
$227K Buy
+483
New +$203K 0.12% 44

Other funds holding LLY

Consilio Wealth Advisors's LLY Position: Q2 2026 in Review

Consilio Wealth Advisors increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $19.4K and bringing the position to 928 shares worth $1.11M. The position accounts for 0.27% of the portfolio, ranked #41.

Consilio Wealth Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Consilio Wealth Advisors held 928 shares of Eli Lilly worth $1.11M as of Q2 2026.
  • Consilio Wealth Advisors bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.27% of Consilio Wealth Advisors's portfolio in Q2 2026, its #41 holding.
  • Consilio Wealth Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Consilio Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.